Early proactive therapeutic drug monitoring program for management of infliximab in inflammatory bowel disease: long-term durability of treatments

被引：0
|
作者：
Sanchez-Hernandez, J. G. [1 ]
Rebollo, N. [1 ]
Munoz, F. [2 ]
Saez-Fernandez, E. M. [1 ]
Rodriguez-Rodriguez, G. [1 ]
Tapia-Artiles, C. [1 ]
Fernandez-Caballero, R. [1 ]
Calvo, M. V. [1 ]
机构：
[1] Hosp Univ Salamanca, Pharm Serv, Salamanca, Spain
[2] Hosp Clin Univ Salamanca, Gastroenterol Serv, Salamanca, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2020年 / 42卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
TDMP002
引用
收藏
页码：232 / 233
页数：2
相关论文
共 50 条
  • [1] Proactive therapeutic drug monitoring of infliximab leads to durability of treatment in children with Inflammatory Bowel Disease
    Chuah, C. W.
    Eldredge, J.
    Magoffin, A.
    O'Loughlin, E., V
    Park, C. J.
    Puppi, J.
    Siew, S.
    Stormon, M.
    Thacker, K.
    Dutt, S.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2099 - i2099
  • [2] LONG-TERM OUTCOMES OF PROACTIVE VERSUS REACTIVE THERAPEUTIC DRUG MONITORING FOR OPTIMIZING INFLIXIMAB THERAPY IN INFLAMMATORY BOWEL DISEASE
    Papamichail, Konstantinos
    Chachu, Karen A.
    Vajravelu, Ravy K.
    Vaughn, Byron P.
    Ni, Josephine
    Cheifetz, Adam S.
    Osterman, Mark T.
    GASTROENTEROLOGY, 2017, 152 (05) : S381 - S382
  • [3] Proactive therapeutic drug monitoring (TDM) of infliximab leads to durability of treatment in children with inflammatory bowel disease
    Chuah, Cher Wei
    Dutt, Shoma
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 325 - 325
  • [4] Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study
    Bautista, Susana Clemente
    Canton, Oscar Segarra
    Padulles-Zamora, Nuria
    Garcia, Sonia Garcia
    Beltran, Marina Alvarez
    Garcia, Maria Larrosa
    Poy, Maria Josep Cabanas
    Sanz-Martinez, Maria Teresa
    Vazquez, Ana
    Torner, Maria Queralt Gorgas
    Miarons, Marta
    PHARMACEUTICS, 2024, 16 (12)
  • [5] Proactive infliximab drug monitoring is superior to conventional management in inflammatory bowel disease
    Raimundo Fernandes, S.
    Bernardo, S.
    Simoes, C.
    Correia, L.
    Moura Santos, P.
    Rita Goncalves, A.
    Valente, A.
    Baldaia, C.
    Tato Marinho, R.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S64 - S65
  • [6] Proactive Infliximab Drug Monitoring Is Superior to Conventional Management in Inflammatory Bowel Disease
    Fernandes, Samuel Raimundo
    Bernardo, Sonia
    Simoes, Carolina
    Goncalves, Ana Rita
    Valente, Ana
    Baldaia, Cilenia
    Santos, Paula Moura
    Correia, Luis Araujo
    Marinho, Rui Tato
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (02) : 263 - 270
  • [7] PROACTIVE INFLIXIMAB DRUG MONITORING IS SUPERIOR TO CONVENTIONAL MANAGEMENT IN INFLAMMATORY BOWEL DISEASE
    Fernandes, Samuel R.
    Bernardo, Sonia
    Simoes, Carolina
    Correia, Luis Araujo
    Moura-Santos, Paula
    Goncalves, Ana R.
    Valente, Ana
    Baldaia, Cilenia
    Marinho, Rui T.
    GASTROENTEROLOGY, 2019, 156 (06) : S1137 - S1137
  • [8] A 3-year prospective study of a multidisciplinary early proactive therapeutic drug monitoring programme of infliximab treatments in inflammatory bowel disease
    German Sanchez-Hernandez, Jose
    Rebollo, Noemi
    Martin-Suarez, Ana
    Victoria Calvo, M.
    Munoz, Fernando
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (06) : 1165 - 1175
  • [9] Long-Term Outcomes of Proactive Therapeutic Drug Monitoring of Adalimumab and Standard of Care in Patients With Inflammatory Bowel Disease
    Dai, Cong
    Jiang, Min
    Yu, Ji-hong
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (08): : 1092 - 1093
  • [10] Proactive Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease Patients Receiving Infliximab and Biosimilars
    Aktay, Atiye
    Odolil, Abel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (12S): : S21 - S21
12345